Piper Sandler Maintains Overweight on Exact Sciences, Raises Price Target to $70

Benzinga · 10/08/2025 12:40
Piper Sandler analyst David Westenberg maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $60 to $70.